When FDA approves generic drugs, why the the same can not be made popular in India.
Is it a mindset of doctors in India or obligation towards the manufacturers of branded drugs?
Why the “Jana Ousadhi” programme is not that popular?
Ultimately we need cheaper drugs for everybody.
FDA Approves Generic Levofloxacin
WASHINGTON — The FDA has approved the first generic versions of the antibiotic levofloxacin (Levaquin) for patients 18 and older.
The drug is indicated to treat mild, moderate, or severe bacterial infections of the skin, sinus, kidney, bladder, and prostate caused by certain germs. It is also used to treat people exposed to inhalational anthrax and some bacterial infections that cause bronchitis and pneumonia.
Like all fluoroquinolones, levofloxacin comes with a boxed warning for an increased risk of tendinitis and tendon rupture, a statement from the FDA said. The risk is elevated in patients older than 60; those taking corticosteroids; and kidney, heart, and lung transplant patients.
The warning also notes the drug may worsen muscle weakness in myasthenia gravis, a chronic autoimmune neuromuscular disease.
Approval for the generic went to 12 companies, including:
- Aurobindo Pharma
- Dr. Reddy’s Laboratories
- Glenmark Generics
- Hi-Tech Pharmacal
- Mylan Pharmaceuticals
- Sagent Strides
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
Generic forms approved include tablet, oral solution, and injectable solution.